(Q73206711)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Phase I study of Doxil and vinorelbine in metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

main subject

metastatic breast cancer

1 reference

1 reference

10

E P Winer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

H J Burstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M J Ramirez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

W P Petros

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K D Clarke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M A Warmuth

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P K Marcom

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

U A Matulonis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L M Parker

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L N Harris

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1113-1116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

Vinorelbine (Navelbine): a third-generation vinca alkaloid

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323200102

7 January 2021

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323200102

7 January 2021

Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323200102

7 January 2021

Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323200102

7 January 2021

Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323200102

7 January 2021

Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323200102

7 January 2021

A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323200102

7 January 2021

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323200102

7 January 2021

Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323200102

7 January 2021

Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323200102

7 January 2021

Identifiers

DOI

10.1023/A:1008323200102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572612%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference